ADRs related to unapproved clinical products: TGA changes

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1648卷 / 1期

关键词：

D O I：

10.1007/s40278-017-28980-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：1 / 1

相关论文

共 50 条

[1] Concerns with the use of unapproved products
Snelson, Harry
[J]. JOURNAL OF SWINE HEALTH AND PRODUCTION, 2009, 17 (04): : 237 - 237
[2] STAKEHOLDER DEMAND FOR INFORMATION RELATED TO PIPELINE PRODUCTS AND UNAPPROVED USES OF APPROVED MEDICINES
Nelson, J. A.
Woltemath, D.
Drozd, M.
Vandigo, J.
[J]. VALUE IN HEALTH, 2017, 20 (05) : A35 - A35
[3] Federal Regulation of Unapproved Chelation Products
Lee, Charles E.
[J]. JOURNAL OF MEDICAL TOXICOLOGY, 2013, 9 (04) : 313 - 317
[4] The Australian TGA has established a new adverse drug reactions (ADRs) unit
[J]. Reactions Weekly, 1999, 781 (1) : 2 - 2
[5] Update on unapproved animal-health products
不详
[J]. JOURNAL OF SWINE HEALTH AND PRODUCTION, 2010, 18 (03): : 144 - 144
[6] FDA goes after unapproved equine products
不详
[J]. JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2015, 246 (01): : 28 - 28
[7] Products in dermatologic surgery: Unapproved treatments or indications
Benedetto, AV
[J]. CLINICS IN DERMATOLOGY, 2000, 18 (02) : 219 - 228
[8] FDA against marketing unapproved quinine products
[J]. Reactions Weekly, 2007, 1133 (1) : 3 - 3
[9] FDA warns companies over unapproved chelation products
[J]. Reactions Weekly, 2010, 1324 (1) : 2 - 2
[10] FDA concerned about unapproved products for sexual enhancement
[J]. Reactions Weekly, 2006, 1111 (1) : 2 - 2

← 1 2 3 4 5 →